Literature DB >> 21653799

Fat mass modifies the association of fat-free mass with symptom-limited treadmill duration in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Na Zhu1, David R Jacobs, Stephen Sidney, Barbara Sternfeld, Mercedes Carnethon, Cora E Lewis, Christina M Shay, Akshay Sood, Claude Bouchard.   

Abstract

BACKGROUND: The assessment of fat mass and fat-free mass in relation to the symptom-limited maximal exercise duration (Max(dur)) of a treadmill test allows for insight into the association of body composition with treadmill performance potential.
OBJECTIVE: We investigated the complex associations between fat mass and fat-free mass and Max(dur) in a population setting.
DESIGN: The Max(dur) of a graded exercise treadmill test and body composition by dual-energy X-ray absorptiometry were estimated in 2413 black and white men and women aged 38-50 y from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort.
RESULTS: The mean Max(dur) was ≈7.5 s shorter per kilogram of fat mass in both men and women and independent of fat-free mass, height, race, television watching, physical activity, systolic blood pressure, lung function, and education. Fat mass modified the association of fat-free mass with the Max(dur) (2-way interaction P < 0.001), and the interaction was stronger in women than in men. In men in the lowest fat-mass quartile, the Max(dur) was 1.3 s longer per kilogram of fat-free mass and was 0.5 s shorter per kilogram of fat-free mass in the highest fat-mass quartile. In contrast, in women with the least fat mass, the Max(dur) was 2.7 s longer per kilogram of fat-free mass and was 2.8 s shorter per kilogram of fat-free mass in the highest fat-mass quartile.
CONCLUSIONS: The Max(dur) was negatively related to fat mass. Fat-free mass in obese people contributed little to the treadmill performance potential as assessed by the Max(dur), although the contribution of fat-free mass was positive in thinner people.

Entities:  

Mesh:

Year:  2011        PMID: 21653799      PMCID: PMC3142718          DOI: 10.3945/ajcn.110.008995

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  43 in total

1.  A comparative analysis of four protocols for maximal treadmill stress testing.

Authors:  M L Pollock; R L Bohannon; K H Cooper; J J Ayres; A Ward; S R White; A C Linnerud
Journal:  Am Heart J       Date:  1976-07       Impact factor: 4.749

2.  Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) Study.

Authors:  G H Hughes; G Cutter; R Donahue; G D Friedman; S Hulley; E Hunkeler; D R Jacobs; K Liu; S Orden; P Pirie
Journal:  Control Clin Trials       Date:  1987-12

3.  Aerobic performance in brothers, dizygotic and monozygotic twins.

Authors:  C Bouchard; R Lesage; G Lortie; J A Simoneau; P Hamel; M R Boulay; L Pérusse; G Thériault; C Leblanc
Journal:  Med Sci Sports Exerc       Date:  1986-12       Impact factor: 5.411

4.  Editorial: Cardiorespiratory fitness.

Authors:  R Mac Kenzie
Journal:  Can Med Assoc J       Date:  1974-07-06       Impact factor: 8.262

5.  Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease.

Authors:  R A Bruce; F Kusumi; D Hosmer
Journal:  Am Heart J       Date:  1973-04       Impact factor: 4.749

Review 6.  Physiological determinants of cardiorespiratory fitness.

Authors:  R J Shephard
Journal:  J Sports Med Phys Fitness       Date:  1967-09       Impact factor: 1.637

7.  Relationship of physical characteristics and life habits to treadmill exercise capacity.

Authors:  A S Leon; D R Jacobs; G DeBacker; H L Taylor
Journal:  Am J Epidemiol       Date:  1981-06       Impact factor: 4.897

8.  Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE--a randomized controlled study.

Authors:  Cris A Slentz; Brian D Duscha; Johanna L Johnson; Kevin Ketchum; Lori B Aiken; Gregory P Samsa; Joseph A Houmard; Connie W Bales; William E Kraus
Journal:  Arch Intern Med       Date:  2004-01-12

9.  CARDIA: study design, recruitment, and some characteristics of the examined subjects.

Authors:  G D Friedman; G R Cutter; R P Donahue; G H Hughes; S B Hulley; D R Jacobs; K Liu; P J Savage
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

10.  Alcohol intake and blood pressure in young adults: the CARDIA Study.

Authors:  A R Dyer; G R Cutter; K Q Liu; M A Armstrong; G D Friedman; G H Hughes; J J Dolce; J Raczynski; G Burke; T Manolio
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

View more
  4 in total

1.  Association of abdominal muscle composition with prediabetes and diabetes: The CARDIA study.

Authors:  Andrea Granados; Achamyeleh Gebremariam; Samuel S Gidding; James G Terry; John Jeffrey Carr; Lyn M Steffen; David R Jacobs; Joyce M Lee
Journal:  Diabetes Obes Metab       Date:  2018-09-21       Impact factor: 6.577

2.  Cardiorespiratory fitness and brain volume and white matter integrity: The CARDIA Study.

Authors:  Na Zhu; David R Jacobs; Pamela J Schreiner; Lenore J Launer; Rachel A Whitmer; Stephen Sidney; Ellen Demerath; William Thomas; Claude Bouchard; Ka He; Guray Erus; Harsha Battapady; R Nick Bryan
Journal:  Neurology       Date:  2015-05-08       Impact factor: 9.910

3.  Cardiorespiratory fitness and cognitive function in middle age: the CARDIA study.

Authors:  Na Zhu; David R Jacobs; Pamela J Schreiner; Kristine Yaffe; Nick Bryan; Lenore J Launer; Rachel A Whitmer; Stephen Sidney; Ellen Demerath; William Thomas; Claude Bouchard; Ka He; Jared Reis; Barbara Sternfeld
Journal:  Neurology       Date:  2014-04-02       Impact factor: 9.910

4.  Insulin resistance since early adulthood and appendicular lean mass in middle-aged adults without diabetes: 20 years of the CARDIA study.

Authors:  Victor W Zhong; Michael P Bancks; Pamela J Schreiner; Cora E Lewis; Lyn M Steffen; James B Meigs; Lauren A Schrader; Melanie Schorr; Karen K Miller; Stephen Sidney; Mercedes R Carnethon
Journal:  J Diabetes Complications       Date:  2018-09-17       Impact factor: 3.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.